Company: TPET
Filing Date: 2025-03-14
Form Type: 10-Q
Source: 0001493152-25-010362
Chunk: 135

Company: Trio Petroleum Corp.
Filing Date: 2025-03-14
Form: 10-Q
Item: Part II, Item 1A
Chunk 135
---
There
                                            have been no other material changes to the risk factors set forth in the section titled “Risk
                                            Factors” included in our Annual Report on Form 10-K for the year ended October 31,
                                            2024, which was filed with the SEC on January 17, 2025 (“2024 Annual Report”).
                                            Our business involves significant risks. You should carefully consider the risks and uncertainties
                                            described in our 2024 Annual Report, together with all of the other information in our 2024
                                            Annual Report and in this Quarterly Report on Form 10-Q, as well as our audited financial
                                            statements and related notes as disclosed in our Amendment No. 2 to Annual Report on Form
                                            10-K/A filed with the SEC on February 27, 2025.

31

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds

None, except as reported
on Current Reports on Form 8-K filed by the Company during the quarterly period covered by this report.

Item
3. Defaults Upon Senior Securities

None.

Item
4. Mine Safety Disclosures

Not applicable.

Item
5. Other Information

(c)
Insider Trading Arrangements

Trading
Plans

On
January 22, 2025, Robin Ross, the Chief Executive Officer and Director of the Company, entered into a 10b5-1 sales plan (the “Ross
10b-5 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Ross 10b-5 Sales Plan
provides for the sale of up to 150,000 shares of common stock and will remain in effect until the earlier of (1) July 22, 2026; or (2)
the date on which an aggregate of 150,000 shares of common stock have been sold under the Ross 10b5 Sales Plan. As of the date of this
Report, none of the shares were sold and no other adjustments were made to the plan during the quarterly period covered by this report.

No
other directors or executive officers of the Company adopted, modified or terminated any contract,
instruction or written plan for the purchase or sale of the Company’s securities that was intended to satisfy the affirmative
defense conditions of Rule 10b5-1(c) or any non-Rule 10b5 trading arrangement, (as defined in Item 408(c